Bank of Nova Scotia
RMD icon

Bank of Nova Scotia’s ResMed RMD Stock Holding History

Bank of Nova Scotia’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.98M Sell
15,294
-5,021
-25% -$1.04M ﹤0.01% 714
2026
Q1 		$4.56M Sell
20,315
-2,522
-11% -$628K 0.01% 598
2025
Q4 		$5.5M Buy
22,837
+4,803
+27% +$1.23M 0.01% 600
2025
Q3 		$4.94M Buy
18,034
+2,480
+16% +$677K 0.01% 553
2025
Q2 		$4.01M Sell
15,554
-97
-0.6% -$23.1K 0.01% 546
2025
Q1 		$3.5M Sell
15,651
-2,484
-14% -$580K 0.01% 526
2024
Q4 		$4.15M Buy
18,135
+856
+5% +$206K 0.01% 557
2024
Q3 		$4.22M Buy
17,279
+3,685
+27% +$823K 0.01% 502
2024
Q2 		$2.6M Sell
13,594
-4,748
-26% -$963K 0.01% 590
2024
Q1 		$3.63M Sell
18,342
-40,266
-69% -$7.38M 0.01% 552
2023
Q4 		$10.1M Buy
58,608
+44,677
+321% +$6.86M 0.02% 414
2023
Q3 		$2.06M Sell
13,931
-33,009
-70% -$5.97M 0.01% 576
2023
Q2 		$10.3M Sell
46,940
-157,968
-77% -$35.2M 0.03% 282
2023
Q1 		$44.9M Buy
204,908
+192,808
+1,593% +$41.8M 0.13% 126
2022
Q4 		$2.52M Sell
12,100
-11
-0.1% -$2.42K 0.01% 593
2022
Q3 		$2.64M Sell
12,111
-24
-0.2% -$5.46K 0.01% 572
2022
Q2 		$2.54M Sell
12,135
-6,026
-33% -$1.28M 0.01% 634
2022
Q1 		$4.4M Sell
18,161
-41,503
-70% -$10M 0.01% 622
2021
Q4 		$15.5M Sell
59,664
-47,235
-44% -$12.3M 0.02% 442
2021
Q3 		$28.2M Sell
106,899
-17,328
-14% -$4.74M 0.05% 286
2021
Q2 		$30.6M Buy
124,227
+96,894
+354% +$20.4M 0.06% 250
2021
Q1 		$5.3M Buy
27,333
+2,814
+11% +$564K 0.01% 553
2020
Q4 		$5.21M Sell
24,519
-4,107
-14% -$819K 0.01% 498
2020
Q3 		$4.91M Sell
28,626
-34,239
-54% -$6.32M 0.01% 470
2020
Q2 		$12.1M Sell
62,865
-41,156
-40% -$6.73M 0.04% 274
2020
Q1 		$15.3M Sell
104,021
-31,633
-23% -$5.04M 0.05% 249
2019
Q4 		$21M Buy
135,654
+2,476
+2% +$357K 0.05% 273
2019
Q3 		$18M Buy
133,178
+109,765
+469% +$14.4M 0.05% 279
2019
Q2 		$2.86M Sell
23,413
-3,729
-14% -$413K 0.01% 537
2019
Q1 		$2.82M Sell
27,142
-3,410
-11% -$352K 0.01% 556
2018
Q4 		$3.48M Buy
30,552
+1,634
+6% +$175K 0.02% 476
2018
Q3 		$3.33M Buy
28,918
+13,334
+86% +$1.46M 0.01% 513
2018
Q2 		$1.61M Sell
15,584
-2,465
-14% -$249K 0.01% 556
2018
Q1 		$1.78M Sell
18,049
-12,691
-41% -$1.2M 0.01% 604
2017
Q4 		$2.6M Sell
30,740
-2,536
-8% -$210K 0.01% 536
2017
Q3 		$2.56M Buy
33,276
+24,686
+287% +$1.89M 0.01% 513
2017
Q2 		$669K Sell
8,590
-23,600
-73% -$1.69M ﹤0.01% 825
2017
Q1 		$2.32M Buy
32,190
+23,600
+275% +$1.63M 0.01% 588
2016
Q4 		$533K Hold
8,590
– – ﹤0.01% 597
2016
Q3 		$556K Hold
8,590
– – ﹤0.01% 502
2016
Q2 		$543K Sell
8,590
-3,200
-27% -$189K ﹤0.01% 471
2016
Q1 		$682K Hold
11,790
– – ﹤0.01% 422
2015
Q4 		$633K Hold
11,790
– – ﹤0.01% 464
2015
Q3 		$601K Buy
11,790
+5,190
+79% +$279K ﹤0.01% 393
2015
Q2 		$372K Buy
6,600
+300
+5% +$18.9K ﹤0.01% 426
2015
Q1 		$452K Buy
6,300
+2,300
+58% +$149K ﹤0.01% 380
2014
Q4 		$224K Buy
+4,000
New +$209K ﹤0.01% 519
2014
Q3 		– Sell
-4,000
Closed -$202K – 583
2014
Q2 		$202K Buy
+4,000
New +$198K ﹤0.01% 542

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of Nova Scotia's RMD Position: Q2 2026 in Review

Bank of Nova Scotia reduced its ResMed (RMD) stake by 25% in Q2 2026, selling an estimated $1.04M and leaving 15,294 shares worth $2.98M. The position accounts for ﹤0.01% of the portfolio, ranked #714.

Bank of Nova Scotia first reported a position in RMD in Q2 2014 and has held it in 48 quarters since. The position peaked at $44.9M in Q1 2023. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Bank of Nova Scotia held 15,294 shares of ResMed worth $2.98M as of Q2 2026.
  • Bank of Nova Scotia sold 5,021 ResMed shares in Q2 2026, an estimated $1.04M.
  • ResMed made up ﹤0.01% of Bank of Nova Scotia's portfolio in Q2 2026, its #714 holding.
  • Bank of Nova Scotia first reported a position in ResMed in Q2 2014 and has held it in 48 quarters since.
  • Bank of Nova Scotia's ResMed position peaked at $44.9M in Q1 2023.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.